Thousand Oaks, CA, United States of America

Dawei Zhang

This inventor holds 30 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Kinase Inhibitors. Top assignees: Amgen Inc., Teligene Ltd., Jiangsu Medolution Ltd. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dawei Zhang. Retrieved from https://idiyas.com/inventor/dawei-zhang-x6ue45uh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 5)

% Patents Active = 76.7

CIPO Patents = 1

EPO Patents = 9 (Patent Applications = 9)

Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 147(Granted Patents)

Location History:

Thousand, CA (US) (2018)
Thousand Oaks, CA (US) (2005 - 2024)

Company Filing History:

Jiangsu Medolution Ltd

patents

4. 1 out of 1

Hangzhouderenyucheng Biotechnology Ltd

7. 2 out of 834,570

Other

patents

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

Substituted Macrocycles

Quinolines

Pyrazolopyrimidines

Heterocyclic Compounds

Aminoquinazolines

Bicyclic Compounds

Phthalazine Compounds

EGFR-T790M

PI3K Inhibitors

Bruton's Tyrosine Kinase

PKB Modulators

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12338251 - Substituted macrocycles useful as kinase inhibitors (2025-06-24),

2. 12017996 - Substituted quinolines and formulations thereof (2024-06-25),

3. 11427559 - Substituted quinolines useful as kinase inhibitors (2022-08-30),

4. 11344553 - Substituted pyrazolopyrimidines useful as kinases inhibitors (2022-05-31),

5. 11034656 - Maleate salts of (E)-N-(3-cyano-7-ethoxy-4-((4-phenoxyphenyl)amino) quinolin-6-yl)-4-(dimethylamino)but-2-enamide and crystalline forms thereof (2021-06-15),

6. 10173995 - Pyridine compounds used as PI3 kinase inhibitors (2019-01-08),

7. 10167264 - Substituted pyrimidines useful as EGFR-T790M kinase inhibitors (2019-01-01),

8. 10159663 - Substituted macrocycles useful as kinases inhibitors and methods of use thereof (2018-12-25),

9. 9873701 - Heterocyclic compounds and their uses (2018-01-23),

10. 9694011 - Substituted pyrazolopyrimidines as kinases inhibitors (2017-07-04),

11. 9550738 - Bicyclic compounds as kinases inhibitors (2017-01-24),

12. 9388170 - Substituted aminoquinazolines useful as kinases inhibitors (2016-07-12),

13. 9388160 - Quinazoline derivatives as kinases inhibitors and methods of use thereof (2016-07-12),

14. 9353062 - Substituted quinolines as bruton's tyrosine kinases inhibitors (2016-05-31),

15. 8901135 - Heterocyclic compounds and their uses (2014-12-02),

Title: The Innovative Journey of Dawei Zhang

Introduction: Dawei Zhang, a talented inventor based in Thousand Oaks, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Dawei Zhang holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for problem-solving, Dawei Zhang has had a successful career marked by his ability to turn creative ideas into tangible solutions. His work has not only revolutionized industries but has also improved the lives of many.

Collaborations: Throughout his career, Dawei Zhang has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the market. His collaborative spirit and dedication to innovation have led to numerous successful projects.

Conclusion: Dawei Zhang's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true visionary in the world of inventions. His impact on various industries is undeniable, and his legacy as an inventor continues to inspire future generations of innovators.

Profile summary based on public USPTO records.